| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SNWV | Future Advance Convertible Promissory Note | Award | $11B | +105K | $105,000.00 | $105K | Aug 5, 2022 | Common Stock | 7K | $15.00 | Direct | F4 | |
| transaction | SNWV | Future Advance Convertible Promissory Note | Conversion of derivative security | -$121K | 0 | Aug 5, 2023 | Common Stock | 8.05K | $15.00 | Direct | F1 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Award | +7K | 7K | Aug 5, 2022 | Common Stock | 7K | $15.00 | Direct | F4 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Disposed to Issuer | -7K | -100% | 0 | Oct 18, 2024 | Common Stock | 7K | $15.00 | Direct | F3 | ||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Award | +7K | 7K | Aug 5, 2022 | Common Stock | 7K | $25.13 | Direct | F4 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Disposed to Issuer | -7K | -100% | 0 | Oct 18, 2024 | Common Stock | 7K | $25.13 | Direct | F3 | ||
| transaction | SNWV | Future Advance Convertible Promissory Note | Award | $50K | $50K | May 9, 2023 | Common Stock | 3.33K | $15.00 | Direct | F5 | |||
| transaction | SNWV | Future Advance Convertible Promissory Note | Conversion of derivative security | $0 | -57.5K | -100% | $0.00 | 0 | May 9, 2024 | Common Stock | 3.83K | $15.00 | Direct | F2 |
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Award | +3.33K | 3.33K | May 9, 2023 | Common Stock | 3.33K | $15.00 | Direct | F5 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Disposed to Issuer | -3.33K | -100% | 0 | Oct 18, 2024 | Common Stock | 3.33K | $15.00 | Direct | F3 | ||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Award | +3.33K | 3.33K | May 9, 2023 | Common Stock | 3.33K | $25.13 | Direct | F5 | |||
| transaction | SNWV | Common Stock Purchase Warrant (right to buy) | Disposed to Issuer | -3.33K | -100% | 0 | Oct 18, 2024 | Common Stock | 3.33K | $25.13 | Direct | F3 | ||
| transaction | SNWV | Stock Option (right to buy) | Award | $0 | +41.3K | $0.00 | 41.3K | Oct 22, 2024 | Common Stock | 41.3K | $14.20 | Direct | F6 | |
| transaction | SNWV | Stock Option (right to buy) | Award | $0 | +1.75K | +4.24% | $0.00 | 43.1K | Dec 31, 2024 | Common Stock | 1.75K | $22.76 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Pursuant to the terms of the Future Advance Convertible Promissory Note issued by SANUWAVE Health, Inc. (the "Company") on August 5, 2022, all principal and accrued interest due as of the maturity date, August 5, 2023, was automatically converted into shares of common stock at a conversion price of $15.00 per share. |
| F2 | Pursuant to the terms of the Future Advance Convertible Promissory Note issued by the Company on May 9, 2023, all principal and accrued interest due as of the maturity date, May 9, 2024, was automatically converted into shares of common stock at a conversion price of $15.00 per share. |
| F3 | On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's warrants were exchanged for an aggregate of 18,084 shares of common stock pursuant to a letter agreement between the reporting person and the Company. |
| F4 | On August 5, 2022, in exchange for $105,000 in cash, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $105,000 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 7,000 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 7,000 shares of common stock at an exercise price of approximately $25.13 per share). |
| F5 | On May 9, 2023, in exchange for $50,000 in cash, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $50,000 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 3,333 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 3,333 shares of common stock at an exercise price of approximately $25.13 per share). |
| F6 | Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date. |
| F7 | Options were fully vested at the grant date. |
All share amounts, exercise prices and conversion prices herein have been retroactively adjusted to reflect the 1-for-375 reverse stock split of the Company's common stock which occurred on October 18, 2024.